Cigna Corporation (CI) Position Lowered by Arizona State Retirement System
Arizona State Retirement System cut its stake in shares of Cigna Corporation (NYSE:CI) by 2.6% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 77,474 shares of the health services provider’s stock after selling 2,100 shares during the period. Arizona State Retirement System’s holdings in Cigna Corporation were worth $12,968,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Mn Services Vermogensbeheer B.V. boosted its position in Cigna Corporation by 3.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 6,847 shares of the health services provider’s stock valued at $938,000 after buying an additional 205 shares during the period. Candriam Luxembourg S.C.A. boosted its position in Cigna Corporation by 20.3% in the first quarter. Candriam Luxembourg S.C.A. now owns 15,839 shares of the health services provider’s stock valued at $2,320,000 after buying an additional 2,672 shares during the period. State of Alaska Department of Revenue bought a new position in Cigna Corporation during the first quarter valued at about $689,000. Columbus Circle Investors boosted its position in Cigna Corporation by 7.0% in the first quarter. Columbus Circle Investors now owns 44,421 shares of the health services provider’s stock valued at $6,507,000 after buying an additional 2,906 shares during the period. Finally, Boys Arnold & Co. Inc. boosted its position in Cigna Corporation by 1.8% in the first quarter. Boys Arnold & Co. Inc. now owns 1,833 shares of the health services provider’s stock valued at $269,000 after buying an additional 33 shares during the period. Institutional investors and hedge funds own 86.91% of the company’s stock.
Shares of Cigna Corporation (NYSE CI) opened at 175.36 on Friday. Cigna Corporation has a 12 month low of $115.03 and a 12 month high of $178.57. The stock has a market cap of $44.15 billion, a P/E ratio of 20.23 and a beta of 0.46. The company has a 50 day moving average of $172.11 and a 200 day moving average of $158.96.
Cigna Corporation (NYSE:CI) last issued its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion during the quarter, compared to analysts’ expectations of $10.26 billion. Cigna Corporation had a net margin of 7.46% and a return on equity of 17.40%. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.98 earnings per share. Equities research analysts expect that Cigna Corporation will post $10.02 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Cigna Corporation (CI) Position Lowered by Arizona State Retirement System” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.watchlistnews.com/cigna-corporation-ci-position-lowered-by-arizona-state-retirement-system/1474250.html.
Several research firms have recently issued reports on CI. Jefferies Group LLC reiterated a “buy” rating and issued a $190.00 price objective (down from $199.00) on shares of Cigna Corporation in a report on Friday, August 4th. Zacks Investment Research cut shares of Cigna Corporation from a “buy” rating to a “hold” rating in a report on Tuesday. Royal Bank Of Canada reiterated a “buy” rating and issued a $185.00 price objective on shares of Cigna Corporation in a report on Wednesday. ValuEngine cut shares of Cigna Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 20th. Finally, BidaskClub cut shares of Cigna Corporation from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Three equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $180.06.
In related news, insider Michael W. Triplett sold 3,700 shares of the business’s stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $174.96, for a total transaction of $647,352.00. Following the completion of the transaction, the insider now owns 21,060 shares in the company, valued at $3,684,657.60. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO David Cordani sold 153,168 shares of the business’s stock in a transaction that occurred on Monday, June 19th. The shares were sold at an average price of $170.20, for a total transaction of $26,069,193.60. Following the transaction, the chief executive officer now owns 421,162 shares of the company’s stock, valued at approximately $71,681,772.40. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 261,014 shares of company stock valued at $44,434,114. Corporate insiders own 1.30% of the company’s stock.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.